Edition:
United Kingdom

People: Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

8.20CAD
19 Jul 2019
Change (% chg)

$-0.06 (-0.73%)
Prev Close
$8.26
Open
$8.27
Day's High
$8.30
Day's Low
$8.20
Volume
18,701
Avg. Vol
45,966
52-wk High
$10.47
52-wk Low
$6.61

Milne, George 

Dr. George M. Milne Jr. Ph.D. has been appointed as Executive Chairman of the Board of the company. Effective April 29, 2019. he was Director of the company. He has over 30 years of experience in pharmaceutical research and product development. He joined Pfizer in 1970 and held a variety of positions conducting both chemistry and pharmacology research. Dr. Milne became director of the department of immunology and infectious diseases at Pfizer in 1981, was its executive director from 1984 to 1985, and was vice president of research and development from 1985 to 1988. He was appointed senior vice president in 1988. In 1993 he was appointed President of Pfizer Central Research and a senior vice president of Pfizer with global responsibility for human and veterinary medicine R&D. Dr. Milne has served on multiple corporate boards including Mettler-Toledo, Inc., MedImmune, Athersys, Biostorage Technologies, Aspreva, and Conor Medsystems. Dr. Milne received his B.Sc. in Chemistry from Yale University and his Ph.D. in Organic Chemistry from MIT.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --